Jonathan W. Simons
Impact in
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism
- Oncology top 0.5%
- CAR-T cell therapy research
Papers in
-
- Cancer, Hypoxia, and Metabolism 26
- Cancer Genomics and Diagnostics 9
- Cancer, Lipids, and Metabolism 9
- Oncology 26
- Co-authors
- Gregg L. Semenza (8 shared papers)Hua Zhong (6 shared papers)Shuming Nie (6 shared papers)Erik Laughner (4 shared papers)David Zagzag (4 shared papers)Colleen F. Hanrahan (5 shared papers)Yun Xing (2 shared papers)Angelo M. De Marzo (6 shared papers)
- Journals
- The Prostate (13 papers)Urology (8 papers)Cancer Research (6 papers)Cancer (4 papers)Biochemical and Biophysical Research Communications (3 papers)
- Partner nations
- United StatesNetherlandsChina
In The Last Decade
Jonathan W. Simons
120 papers receiving 20.3k citations
Jonathan W. Simons's Hit Papers
Peers
Comparison fields: 5 of 176
- Cancer Research 6.3k
- Oncology 4.8k
- Molecular Biology 9.6k
- Immunology 2.5k
- Pulmonary and Respiratory Medicine 3.5k
Countries citing papers authored by Jonathan W. Simons
This map shows the geographic impact of Jonathan W. Simons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan W. Simons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan W. Simons more than expected).
Fields of papers citing papers by Jonathan W. Simons
This network shows the impact of papers produced by Jonathan W. Simons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan W. Simons. The network helps show where Jonathan W. Simons may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan W. Simons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Hit paper breakdown → | 1999 | 1983 |
| 2 | Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers Hit paper breakdown → | 1990 | 1519 |
| 3 | Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Hit paper breakdown → | 2000 | 1280 |
| 4 | In vivo molecular and cellular imaging with quantum dots Hit paper breakdown → | 2004 | 1038 |
| 5 | The genomic complexity of primary human prostate cancer Hit paper breakdown → | 2011 | 1017 |
| 6 | Nanotechnology Applications in Cancer Hit paper breakdown → | 2007 | 939 |
| 7 | Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group Hit paper breakdown → | 1999 | 880 |
| 8 | Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response Hit paper breakdown → | 1990 | 815 |
| 9 | Phenotype of mice lacking functional Deleted in colorectal cancer (Dec) gene Hit paper breakdown → | 1997 | 668 |
| 10 | 2003 | 637 | |
| 11 | 2000 | 544 | |
| 12 | 1995 | 533 | |
| 13 | 2001 | 531 | |
| 14 | Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. | 1997 | 501 |
| 15 | 2007 | 442 | |
| 16 | 1999 | 410 | |
| 17 | 2013 | 409 | |
| 18 | Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer. | 1999 | 403 |
| 19 | A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. | 2001 | 329 |
| 20 | 2008 | 323 |
About Jonathan W. Simons
Jonathan W. Simons is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 121 papers that have together received 21.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (26 papers), Prostate Cancer Treatment and Research (23 papers), Virus-based gene therapy research (16 papers), Immunotherapy and Immune Responses (15 papers), Cancer Genomics and Diagnostics (9 papers), RNA Interference and Gene Delivery (9 papers), Cancer, Lipids, and Metabolism (9 papers) and Prostate Cancer Diagnosis and Treatment (9 papers). The work is most often cited by research in Cancer Research (6.3k citations), Oncology (4.8k citations), Molecular Biology (9.6k citations), Immunology (2.5k citations) and Pulmonary and Respiratory Medicine (3.5k citations). Jonathan W. Simons has collaborated with scholars based in United States, Netherlands and China. Frequent co-authors include Gregg L. Semenza, Hua Zhong, Shuming Nie, Erik Laughner, David Zagzag, Colleen F. Hanrahan, Hua Zhong, Yun Xing, Angelo M. De Marzo and Fray F. Marshall. Their work appears in journals such as The Prostate, Urology, Cancer Research, Cancer and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.